Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 23, No 15 (May 20), 2005: pp. 3636-3637
© 2005 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.05.378

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bakken, K.
Right arrow Articles by Eggen, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bakken, K.
Right arrow Articles by Eggen, A. E.
Related Articles
Right arrowRelated Reply
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

CORRESPONDENCE

The Impact of Hormone Replacement Therapy on the Incidence of Breast Cancer in Norway

Kjersti Bakken, Eiliv Lund

Departments of Community Medicine and Pharmacy, University of Tromsø, Tromsø, Norway

Anna Elise Eggen

Department of Pharmacy, University of Tromsø, Tromsø, Norway

To the Editor:

In a letter to the Editor of the Journal of Clinical Oncology, Hemminki et al1 analyzed the effects of nationwide screening activity on the age-incidence relationships of breast cancer.

Referring to Swedish data, they concluded that the large increase in the incidence of breast cancer is mainly due to mammographic screening. Hemminki et al also referred to an article by Zahl et al2 that made the same assumption. Zahl et al assumed the increase in cancer incidence in Norwegian women aged 50 to 69 years to be closely associated with the introduction of screening in the counties. They considered it unlikely to be caused by other factors such as hormone replacement therapy (HRT). The authors did not, however, present individual data on HRT.

In the Norwegian Women and Cancer (NOWAC) study, we found the adjusted relative risk (RR) of breast cancer in current users compared with never-users of HRT to be 2.1 (95% CI, 1.7 to 2.7).3 In the multivariate analyses, we adjusted for time since menopause, age at menarche, ever use of oral contraceptives, body mass index, maternal history of breast cancer, parity, age at first childbirth, and living in a region with a screening program. The prevalence of current use was as high as 35% and the estimated attributable risk of HRT was 27%.

The present reanalysis provides individual data on women’s use of HRT as well as mammograms taken. In postmenopausal women aged 45 to 64 years who never used HRT, we found a 20% increase in the risk of having breast cancer diagnosed by administering a mammogram (RR, 1.2; 95% CI, 0.9 to 1.7). Current users of HRT doubled their relative risk of having breast cancer (RR, 2.2; 95% CI, 1.5 to 3.1), whereas users who had a mammogram had an RR of 2.4 (95% CI, 1.8 to 2.3; Fig 1). We conclude that in the study period (1996 to 2000), use of HRT in Norwegian women aged 45 to 64 years had greater impact on the increase in breast cancer incidence than did screening.



View larger version (68K):
[in this window]
[in a new window]
 
Fig 1. Relative risk of breast cancer according to use of hormone replacement therapy (HRT) and mammography

 
Authors' Disclosures of Potential Conflicts of Interest

The authors indicated no potential conflicts of interest.

REFERENCES

1. Hemminki K, Rawal R, Bermejo J: Mammographic screening is dramatically changing age-incidence data for breast cancer. J Clin Oncol 22 : 4652 -4653, 2004[Free Full Text]

2. Zahl PH, Strand BH, Maehlen J: Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: Prospective cohort study. BMJ 328 : 921 -924, 2004[Abstract/Free Full Text]

3. Bakken K, Alsaker E, Eggen A, et al: Hormone replacement therapy and incidence of hormone dependent cancers in the Norwegian Women and Cancer (NOWAC) study. Int J Cancer 112 : 130 -134, 2004[CrossRef][Medline]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Reply

  • In Reply:
    Kari Hemminki and Justo Lorenzo Bermego
    JCO 2005 23: 3637-3638 [Full Text]



This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bakken, K.
Right arrow Articles by Eggen, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bakken, K.
Right arrow Articles by Eggen, A. E.
Related Articles
Right arrowRelated Reply
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2005 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online